Cargando…
Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876756/ https://www.ncbi.nlm.nih.gov/pubmed/24757239 http://dx.doi.org/10.2337/dc14-0222 |
| _version_ | 1782433285581832192 |
|---|---|
| author | Goldfine, Allison B. Jablonski, Kathleen A. Shoelson, Steven E. Creager, Mark A. |
| author_facet | Goldfine, Allison B. Jablonski, Kathleen A. Shoelson, Steven E. Creager, Mark A. |
| author_sort | Goldfine, Allison B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4876756 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48767562016-05-31 Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 Goldfine, Allison B. Jablonski, Kathleen A. Shoelson, Steven E. Creager, Mark A. Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2014-05 2014-04-10 /pmc/articles/PMC4876756/ /pubmed/24757239 http://dx.doi.org/10.2337/dc14-0222 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Comments and Responses Goldfine, Allison B. Jablonski, Kathleen A. Shoelson, Steven E. Creager, Mark A. Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title | Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_full | Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_fullStr | Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_full_unstemmed | Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_short | Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139 |
| title_sort | response to comment on goldfine et al. targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (tinsal-fmd). diabetes care 2013;36:4132–4139 |
| topic | Online Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876756/ https://www.ncbi.nlm.nih.gov/pubmed/24757239 http://dx.doi.org/10.2337/dc14-0222 |
| work_keys_str_mv | AT goldfineallisonb responsetocommentongoldfineetaltargetinginflammationusingsalsalateinpatientswithtype2diabeteseffectsonflowmediateddilationtinsalfmddiabetescare20133641324139 AT jablonskikathleena responsetocommentongoldfineetaltargetinginflammationusingsalsalateinpatientswithtype2diabeteseffectsonflowmediateddilationtinsalfmddiabetescare20133641324139 AT shoelsonstevene responsetocommentongoldfineetaltargetinginflammationusingsalsalateinpatientswithtype2diabeteseffectsonflowmediateddilationtinsalfmddiabetescare20133641324139 AT creagermarka responsetocommentongoldfineetaltargetinginflammationusingsalsalateinpatientswithtype2diabeteseffectsonflowmediateddilationtinsalfmddiabetescare20133641324139 AT responsetocommentongoldfineetaltargetinginflammationusingsalsalateinpatientswithtype2diabeteseffectsonflowmediateddilationtinsalfmddiabetescare20133641324139 |